MLYS EBITDA Growth
Mineralys Therapeutics Inc · EBITDA Growth
MLYS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-83.28%period ending
MLYS TTM EBITDA YoY % (-6351.54% → -83.28%)
Year-over-year change
High-resolution chart · PNG
MLYS ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -83.2762% | |
| 19.4914% | |
| 13.0367% | |
| -11.8297% | |
| -59.448% | |
| -107.6815% | |
| -147.3996% | |
| -228.8985% | |
| -418.4888% | |
| -730.4007% | |
| -4,377.035% | |
| -6,351.5436% |